Dudediligence.

BioLife Solutions, Inc

BLFSNASDAQ · Electromedical & Electrotherapeutic Apparatus
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$21.4MSep ’24$15.1MDec ’24$22.1MMar ’25$25.4MJun ’25$28.1MSep ’25$18.8MDec ’25$27.5MMar ’26$28.5MJun ’26
Net income, by quarter
−$1.7MSep ’24$12.5MDec ’24−$448,000Mar ’25−$15.8MJun ’25$621,000Sep ’25$11.1MDec ’25$1.2MMar ’26$45.1MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$119.2M$76.2M$68.0M$74.6M$96.2M
Gross profitnone on filenone on file$41.3M$50.1M$62.1M
Operating income−$35.2M−$5.9M−$17.2M−$4.5M−$16.6M
Net income−$8.9M−$139.8M−$68.0M−$20.2M−$4.6M
Operating cash flow−$4.6M−$8.5M−$12.5M$8.4M$20.1M
Free cash flow−$13.0M−$18.9M−$18.9M$5.2M$10.6M
Cash$69.9M$19.4M$27.9M$91.5M$33.0M
Debt$7.2M$25.6M$23.8M$15.9M$5.0M
Shares outstanding41.8M42.8M45.2M46.9M48.2M